12-6386402-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002342.3(LTBR):c.625A>G(p.Thr209Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,612,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002342.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LTBR | NM_002342.3 | c.625A>G | p.Thr209Ala | missense_variant | 6/10 | ENST00000228918.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LTBR | ENST00000228918.9 | c.625A>G | p.Thr209Ala | missense_variant | 6/10 | 1 | NM_002342.3 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.0000792 AC: 12AN: 151492Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251402Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135898
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461304Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 726982
GnomAD4 genome ? AF: 0.0000792 AC: 12AN: 151492Hom.: 0 Cov.: 30 AF XY: 0.0000541 AC XY: 4AN XY: 73912
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.625A>G (p.T209A) alteration is located in exon 6 (coding exon 6) of the LTBR gene. This alteration results from a A to G substitution at nucleotide position 625, causing the threonine (T) at amino acid position 209 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at